Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
December 2015—Luminex received FDA clearance for its Aries System and Aries HSV 1&2 Assay. Aries is a sample-to-answer molecular diagnostics platform designed to increase laboratory efficiency, ensure result accuracy, and fit into a lean laboratory environment.
December 2015—U.S. Arkray has been awarded a three-year agreement for automated urinalysis with Novation.
December 2015—InSphero has launched a 14-Day Hepatotoxicity Testing Service designed to meet increased demand for contract screening in its patent-pending 3D InSight Human Liver Microtissues. The service streamlines toxicity testing of compounds in InSphero’s 3-D liver microtissues by initiating regular screening runs on the first Tuesday of each month, at $990 per compound.
Mopec introduced the Mopec MB800 touchscreen grossing station. Its interactive touchscreen display, which highlights essential grossing station operational information, monitors formalin level, bio waste level, filter usage duration, and ventilation performance. The high-output, touch-free LED lighting system permits adjustments in color and intensity and uniformly illuminates the dissection space, which offers interchangeable grid plates and cutting board surface options.
December 2015—Leavitt Medical’s tissue array, BxChip, allows six needle core specimens to be placed in one block, enabling labs to reduce slide production by one-sixth. Labs that use BxChip find significant savings in the technical component.
December 2015—American Medical Technologists announced the approval of the AMT Medical Technologist (MT) exam by the California Department of Public Health, Laboratory Field Services.
December 2015—DeNovo Sciences announced that the company will operate under the name Celsee Diagnostics, effective immediately.
December 2015—New England Biolabs released its NEBNext Ultra II DNA Library Prep Kit for Illumina next-generation sequencing systems. The reagents for each step in the library preparation workflow have been reformulated to enable high-yield preparation—from a variety of sample types, including formalin-fixed, paraffin-embedded samples—of high-quality libraries, from 500 picograms to 1 microgram of input DNA.
December 2015—Luminex received CE-IVD marking for its NxTAG Respiratory Pathogen Panel. The panel detects 21 clinically relevant viral and bacterial respiratory pathogens, including the atypical bacteria Chlamydophila pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila.
December 2015—NeoGenomics has reached an agreement to acquire Clarient and its wholly owned subsidiary Clarient Diagnostic Services. Clarient, a unit of GE Healthcare’s Life Sciences business, is based in Houston and in Aliso Viejo, Calif., and has approximately 415 employees. Clarient had 2014 revenue of $127 million.
